• Filing Date: 2019-05-14
  • Form Type: 10-Q/A
  • Description: Quarterly report (Amendment)
v3.19.1
STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]        
Grant income $ 150,769 $ 114,271 $ 277,183 $ 210,586
Operating Expenses:        
Research and development 2,525,460 2,962,297 5,657,648 5,288,311
General & administrative 1,931,909 1,375,410 3,960,597 4,074,723
Total operating expenses 4,457,369 4,337,707 9,618,245 9,363,034
Operating loss (4,306,600) (4,223,436) (9,341,062) (9,152,448)
Other income 18,216 17,691 36,127 35,273
(Loss) gain on derivative instruments (967,171) 1,154,815 4,589,135 196,585
Other non-operating gain (loss) (730,823) (768,810) 421,353 (22,109)
Interest expense, net (461,303) (888,395) (907,332) (1,953,266)
Net loss available to common shareholders $ (6,447,681) $ (4,708,135) $ (5,201,779) $ (10,895,965)
Net loss per common share        
Basic $ (0.22) $ (0.31) $ (0.18) $ (0.81)
Diluted $ (0.22) $ (0.31) $ (0.19) $ (0.81)
Weighted average common shares outstanding        
Basic 29,113,910 15,210,296 28,543,417 13,403,878
Diluted 29,113,910 15,210,296 28,548,818 13,403,878